Google DeepMind's Latest AI Model Is Poised to Revolutionize Drug Discovery

Researchers at Google DeepMind have developed AlphaFold 3, an AI model that can predict the structure of and interactions between biological molecules including proteins, DNA and RNA, and small molecules that could function as drugs. Google DeepMind will make the model available for non-commercial use through AlphaFold server. The landmark innovation, the details of which were published in the journal Nature on May 8, is likely to dramatically accelerate biological research. "It's a big milestone for us today, announcing AlphaFold 3," said Demis Hassabis, CEO of Google DeepMind, at a briefing on May 7 announcing the breakthrough. "Biology is a dynamic system and you have to understand how properties of biology emerge through the interactions between different molecules in the cell. You can think of AlphaFold 3 as our first big step towards that."